GT
| |
Ghost Tree Capital, LLC13F | |
| Ghost Tree Capital, LLC | |
| Last update 2024-11-14 | 54 Stocks (9 new) |
| Value $331.00 Mil | Turnover 23 % |
Ghost Tree Capital, LLC Top Holdings of 2024-09-30
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBI
PUT
| SPDR Biotech ETF | 300,000 | 29,640.0 | 0% | 8.950 | 0% | 0.410 | +17.08% | -3.36% | 5,144.9 | ||
BHVN
CALL
| Biohaven Ltd | 348,778 | 17,428.4 | 0% | 5.260 | 0% | 0.350 | -20.94% | -62.70% | 1,422.4 | Biotechnology | |
SRPT | Sarepta Therapeutics Inc | 120,000 | 14,986.8 | +118.18% | 4.530 | +2.45% | 0.130 | -64.39% | -85.06% | 1,785.7 | Biotechnology | |
NVO | Novo Nordisk AS | 110,000 | 13,097.7 | New Holding | 3.960 | +3.96% | 0.000 | +6.49% | -18.58% | 306,282.2 | Drug Manufacturers | |
BPMC | Blueprint Medicines Corp | 140,000 | 12,950.0 | +250.00% | 3.910 | +2.79% | 0.220 | +59.95% | +48.25% | 8,350.5 | Biotechnology | |
AXSM | Axsome Therapeutics Inc | 135,000 | 12,132.5 | -10.00% | 3.660 | -0.38% | 0.280 | +11.14% | +28.80% | 5,365.8 | Biotechnology | |
TARS | Tarsus Pharmaceuticals Inc | 350,000 | 11,511.5 | +48.94% | 3.480 | +1.14% | 0.920 | -15.61% | -29.24% | 1,646.1 | Biotechnology | |
CATX | Perspective Therapeutics Inc | 750,000 | 10,012.5 | -18.92% | 3.020 | -0.55% | 1.110 | +104.10% | +24.76% | 295.4 | Medical Devices & Instruments | |
CGON | CG Oncology Inc | 250,000 | 9,432.5 | -3.85% | 2.850 | -0.10% | 0.370 | +38.59% | -6.83% | 2,036.7 | Biotechnology | |
ROIV | Roivant Sciences Ltd | 800,000 | 9,232.0 | -20.00% | 2.790 | -0.66% | 0.110 | +15.21% | -3.97% | 7,722.6 | Biotechnology |
Ghost Tree Capital, LLC's Historical Top Holdings Breakdowns
Ghost Tree Capital, LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
BHVN | Biohaven Ltd | 2024-09-30 | Sold Out Sold Out | -5.33% | 33.79 ($38.91) 51.18 | $13.93 | -64.20% | Sold Out | 0 | -490,000 | |
NVO | Novo Nordisk AS | 2024-09-30 | New Buy New Buy | +3.96% | 119.07 ($133.36) 145.42 | $68.93 | -48.31% | New holding | 110,000 | 110,000 | |
BPMC | Blueprint Medicines Corp | 2024-09-30 | Add Add | +2.79% | 84.1 ($99.33) 120.5 | $129.30 | 30.17% | Add 250% | 140,000 | 100,000 | |
SRPT | Sarepta Therapeutics Inc | 2024-09-30 | Add Add | +2.45% | 124.33 ($138.24) 156.75 | $18.17 | -86.86% | Add 118.18% | 120,000 | 65,000 | |
MLTX | MoonLake Immunotherapeutics | 2024-09-30 | Reduce Reduce | -2.36% | 40.15 ($46.86) 55.4 | $49.00 | 4.57% | Reduce -57.2% | 128,411 | -171,589 | |
VRDN | Viridian Therapeutics Inc | 2024-09-30 | Reduce Reduce | -2.09% | 12.16 ($16.35) 23.33 | $17.04 | 4.22% | Reduce -87.24% | 75,000 | -512,708 | |
JANX | Janux Therapeutics Inc | 2024-09-30 | Add Add | +1.92% | 35.29 ($43.5) 50.26 | $25.15 | -42.18% | Add 280% | 190,000 | 140,000 | |
SLNO | Soleno Therapeutics Inc | 2024-09-30 | Reduce Reduce | -1.92% | 39.73 ($47.87) 53.55 | $81.56 | 70.39% | Reduce -50% | 150,000 | -150,000 | |
ALNY | Alnylam Pharmaceuticals Inc | 2024-09-30 | Sold Out Sold Out | -1.71% | 233.81 ($260.36) 287.01 | $314.94 | 20.96% | Sold Out | 0 | -22,500 | |
PCVX | Vaxcyte Inc | 2024-09-30 | Reduce Reduce | -1.66% | 70.52 ($90.12) 117.12 | $35.93 | -60.13% | Reduce -46.67% | 80,000 | -70,000 |
Ghost Tree Capital, LLC Total Holding History ($B)
Ghost Tree Capital, LLC's Asset Allocation
Ghost Tree Capital, LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Ghost Tree Capital, LLC's Hypothetical Growth since 2024-09-30
Ghost Tree Capital, LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Ghost Tree Capital, LLC's Holdings Heat Map
Size field:
Ghost Tree Capital, LLC's Holdings Bubble Chart
Ghost Tree Capital, LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers